NormOxys Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
11
- Latest Deal Type
-
Out of Business
NormOxys General Information
Description
Developer of small molecule drugs designed to help in the treatment of cancer. The company's drugs offer a novel allosteric modulator of the affinity of oxygen to hemoglobin which enhances the body's ability to deliver oxygen to diseased tissues, enabling patients to get non-toxic drugs.
Contact Information
Website
www.normoxys.comCorporate Office
- 300 Market Street
- Boston, MA 02135
- United States
Corporate Office
- 300 Market Street
- Boston, MA 02135
- United States
NormOxys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Sep-2018 | Completed | Out of Business | |||
| 3. Later Stage VC | 16-Nov-2011 | Completed | Clinical Trials - Phase 1 | |||
| 2. Later Stage VC (Series B) | 25-Mar-2010 | $18.6M | $26.6M | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC (Series A) | 18-Nov-2008 | $7.98M | $7.98M | Completed | Startup |
NormOxys Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B1 | ||||||||
| Series B | ||||||||
| Series A | 1,958,977 | $0.000100 | 5% | $4.44 | $4.44 | 1x | $4.44 | 25.19% |
NormOxys Comparisons
Industry
Financing
Details
NormOxys Competitors (34)
One of NormOxys’s 34 competitors is Actym Therapeutics, a Venture Capital-Backed company based in Berkeley, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Actym Therapeutics | Venture Capital-Backed | Berkeley, CA | ||||
| Priothera | Venture Capital-Backed | Dublin, Ireland | ||||
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Auron Therapeutics | Venture Capital-Backed | Newton, MA | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX |
NormOxys Patents
NormOxys Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3787634-A1 | Inositol-based immunotherapies | Inactive | 03-May-2018 | ||
| EP-3787634-A4 | Inositol-based immunotherapies | Inactive | 03-May-2018 | ||
| US-20210361680-A1 | Inositol-based immunotherapies | Inactive | 03-May-2018 | ||
| WO-2019213462-A1 | Inositol-based immunotherapies | Inactive | 03-May-2018 | ||
| EP-2968617-A1 | Myo-inositol trispyrophosphate as an anti-obesity agent | Inactive | 15-Mar-2013 | A61K31/6615 |
NormOxys Signals
NormOxys FAQs
-
When was NormOxys founded?
NormOxys was founded in 2004.
-
Where is NormOxys headquartered?
NormOxys is headquartered in Boston, MA.
-
What is the size of NormOxys?
NormOxys has 11 total employees.
-
What industry is NormOxys in?
NormOxys’s primary industry is Drug Discovery.
-
Is NormOxys a private or public company?
NormOxys is a Private company.
-
What is NormOxys’s current revenue?
The current revenue for NormOxys is .
-
How much funding has NormOxys raised over time?
NormOxys has raised $28.7M.
-
Who are NormOxys’s competitors?
Actym Therapeutics, Priothera, Kite Pharma, Auron Therapeutics, and Rein Therapeutics are some of the 34 competitors of NormOxys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process